Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease

References

• Andreasson S, Allebeck P, Romelsjö A. Alcohol and mortality among young men: longitudinal study of Swedish conscripts. Br Med J 1988; 296: 1021–5
   PubMed Web of Science ®Google Scholar
• Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Jr, et al. Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med 1997; 337: 1705–14
   PubMed Web of Science ®Google Scholar
• Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 2006; 166: 2437–45
   PubMed Web of Science ®Google Scholar
• Miller DJ, Ishimaru H, Klatskin G. Non-alcoholic liver disease mimicking alcoholic hepatitis and cirrhosis [abstract]. Gastroenterology 1979; 77: A27
   Web of Science ®Google Scholar
• Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979; 67: 811–6
   PubMed Web of Science ®Google Scholar
• Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434
   PubMed Web of Science ®Google Scholar
• AGA technical review in nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705–25.
   PubMedGoogle Scholar
• Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91–100
   PubMed Web of Science ®Google Scholar
• Suzuki A, Angulo P, St Sauver J, Muto A, Okada T, Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol 2007; 102: 1912–9
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865–73
   PubMed Web of Science ®Google Scholar
• Farrell G, Larter C. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99–112
   PubMed Web of Science ®Google Scholar
• Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: A meta-analysis. Clin Gastroenterol Hepatol 2005; 3: 1150–9
   PubMed Web of Science ®Google Scholar
• Westin J, Lagging LM, Spak F, Aires N, Svensson E, Lindh M, et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 2002; 9: 235–41
   PubMed Web of Science ®Google Scholar
• Mathiesen UL, Franzen LE, Fryden A, Foberg U, Bodemar G. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol 1999; 34: 85–91
   PubMed Web of Science ®Google Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467–74
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202–19
   PubMed Web of Science ®Google Scholar
• Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med 1998; 158: 1789–95
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggianni F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63
   PubMed Web of Science ®Google Scholar
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.
   PubMed Web of Science ®Google Scholar
• Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898–906
   PubMed Web of Science ®Google Scholar
• Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006; 44: 874–80
   PubMed Web of Science ®Google Scholar
• Hayashi PH, Harrison SA, Torgerson S, Perez TA, Nochajski T, Russel M. Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. Am J Gastroenterol 2004; 99: 76–81
   PubMed Web of Science ®Google Scholar
• Fiellin DA, Reid MC, O'Connor PG. Outpatient management of patients with alcohol problems. Ann Intern Med 2000; 133: 815–27
   PubMed Web of Science ®Google Scholar
• Romelsjo A, Leifman H, Nystrom S. A comparative study of two methods for the measurement of alcohol consumption in the general population. Int J Epidemiol 1995; 24: 929–36
   PubMed Web of Science ®Google Scholar
• Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002; 35: 635–8
   PubMed Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005; 3: 1260–8
   PubMed Web of Science ®Google Scholar
• Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB, Jr, Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 2000; 23: 1630–6
   PubMed Web of Science ®Google Scholar
• Zein C, Unalp A, Colvin R, McCullough AJ. Advanced fibrosis in NAFLD is associated with lifetime alcohol use, diabetes, and age but not with lifetime cigarette smoking [abstract]. Hepatology 2007; 46: 739A
   Web of Science ®Google Scholar
• Day CP. From fat to inflammation. Gastroenterology 2006; 130: 207–10
   PubMed Web of Science ®Google Scholar
• Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, et al. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res ;:S 2005; 29: 259S–63
   PubMed Web of Science ®Google Scholar
• Lieber CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 2004; 36: 511–29
   PubMed Web of Science ®Google Scholar
• Orellana M, Rodrigo R, Varela N, Araya J, Poniachik J, Csendes A, et al. Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients. Hepatol Res 2006; 34: 57–63
   PubMed Web of Science ®Google Scholar
• Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Müller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025–9
   PubMed Web of Science ®Google Scholar
• Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994; 20: 1442–9
   PubMed Web of Science ®Google Scholar
• Loria P, Lonardo A, Carulli N. Should non-alcoholic fatty liver disease be renamed?. Dig Dis 2005; 23: 72–82
   PubMed Web of Science ®Google Scholar